CHARLES M BAUM Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CHARLES M BAUM.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CHARLES M BAUM. CHARLES M BAUM is Director in IMMUNOMEDICS INC ($IMMU) and in ARRAY BIOPHARMA INC ($ARRY) and Director in ARRAY BIOPHARMA INC ($ARRY) and President & CEO in Mirati Therapeutics, Inc. ($MYG) and President and CEO in Mirati Therapeutics, Inc. ($MYG) and Director in PMV Pharmaceuticals, Inc. ($PMVP).
Latest Insider Trading Transactions of CHARLES M BAUM
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARRY, IMMU, MYG, PMVP
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 21 2021 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Option Exercise | M | 8.49 | 40,000 | 339,600 | 47,204 | |
| Jun 21 2021 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 166.73 | 1,023 | 170,566 | 112,714 | 113.7 K to 112.7 K (-0.90 %) |
| Jun 21 2021 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 166.07 | 20,823 | 3,457,986 | 113,737 | 134.6 K to 113.7 K (-15.47 %) |
| Jun 21 2021 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 164.91 | 13,338 | 2,199,499 | 134,560 | 147.9 K to 134.6 K (-9.02 %) |
| Jun 21 2021 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 164.07 | 4,816 | 790,182 | 147,898 | 152.7 K to 147.9 K (-3.15 %) |
| Jun 21 2021 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Buy | M | 8.49 | 40,000 | 339,600 | 152,714 | 112.7 K to 152.7 K (+35.49 %) |
| Apr 07 2021 | PMVP | PMV Pharmaceutical ... | BAUM CHARLES M | Director | Option Exercise | A | 34.11 | 32,677 | 1,114,612 | 32,677 | |
| Jan 28 2021 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Option Exercise | M | 5.40 | 2,292 | 12,377 | 100,273 | |
| Jan 28 2021 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Buy | M | 5.40 | 2,292 | 12,377 | 112,714 | 110.4 K to 112.7 K (+2.08 %) |
| Jan 20 2021 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Option Exercise | M | 27.00 | 3,245 | 87,615 | 181,755 | |
| Jan 20 2021 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Option Exercise | A | 214.47 | 30,742 | 6,593,237 | 30,742 | |
| Jan 20 2021 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Buy | M | 27.00 | 3,245 | 87,615 | 110,422 | 107.2 K to 110.4 K (+3.03 %) |
| Jan 20 2021 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Grant | A | 0.00 | 19,665 | 0 | 107,177 | 87.5 K to 107.2 K (+22.47 %) |
| Jan 08 2021 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 210.28 | 4,421 | 929,648 | 87,512 | 91.9 K to 87.5 K (-4.81 %) |
| Jan 08 2021 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 215.76 | 90 | 19,418 | 91,933 | 92 K to 91.9 K (-0.10 %) |
| Dec 31 2020 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Gift | G | 0.00 | 10,000 | 0 | 92,023 | 102 K to 92 K (-9.80 %) |
| Dec 21 2020 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Option Exercise | M | 8.49 | 40,000 | 339,600 | 87,204 | |
| Dec 21 2020 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 240.23 | 317 | 76,153 | 102,023 | 102.3 K to 102 K (-0.31 %) |
| Dec 21 2020 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 238.76 | 100 | 23,876 | 102,340 | 102.4 K to 102.3 K (-0.10 %) |
| Dec 21 2020 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 237.26 | 2,020 | 479,255 | 102,440 | 104.5 K to 102.4 K (-1.93 %) |
| Dec 21 2020 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 236.17 | 4,250 | 1,003,732 | 104,460 | 108.7 K to 104.5 K (-3.91 %) |
| Dec 21 2020 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 235.20 | 493 | 115,956 | 108,710 | 109.2 K to 108.7 K (-0.45 %) |
| Dec 21 2020 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 234.26 | 22,932 | 5,371,998 | 109,203 | 132.1 K to 109.2 K (-17.35 %) |
| Dec 21 2020 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 233.43 | 9,888 | 2,308,145 | 132,135 | 142 K to 132.1 K (-6.96 %) |
| Dec 21 2020 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Buy | M | 8.49 | 40,000 | 339,600 | 142,023 | 102 K to 142 K (+39.21 %) |
| Oct 23 2020 | IMMU | IMMUNOMEDICS INC | BAUM CHARLES M | Director | Option Exercise | D | 0.00 | 3,718 | 0 | 0 | |
| Oct 23 2020 | IMMU | IMMUNOMEDICS INC | BAUM CHARLES M | Director | Option Exercise | D | 0.00 | 46,117 | 0 | 0 | |
| Oct 23 2020 | IMMU | IMMUNOMEDICS INC | BAUM CHARLES M | Director | Sell | D | 0.00 | 9,667 | 0 | 0 | 9.7 K to 0 (-100.00 %) |
| Jul 24 2020 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Gift | G | 0.00 | 5,000 | 0 | 102,023 | 107 K to 102 K (-4.67 %) |
| Jun 22 2020 | IMMU | IMMUNOMEDICS INC | BAUM CHARLES M | Director | Option Exercise | A | 33.62 | 6,540 | 219,875 | 6,540 | |
| Jun 22 2020 | IMMU | IMMUNOMEDICS INC | BAUM CHARLES M | Director | Grant | A | 0.00 | 3,718 | 0 | 13,385 | 9.7 K to 13.4 K (+38.46 %) |
| Apr 28 2020 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Option Exercise | M | 5.40 | 557 | 3,008 | 102,565 | |
| Apr 28 2020 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Buy | M | 5.40 | 557 | 3,008 | 107,023 | 106.5 K to 107 K (+0.52 %) |
| Apr 20 2020 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Option Exercise | M | 8.49 | 40,000 | 339,600 | 127,204 | |
| Apr 20 2020 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 91.63 | 4,290 | 393,092 | 106,466 | 110.8 K to 106.5 K (-3.87 %) |
| Apr 20 2020 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 90.41 | 25,184 | 2,276,958 | 110,756 | 135.9 K to 110.8 K (-18.53 %) |
| Apr 20 2020 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 89.59 | 10,526 | 943,058 | 135,940 | 146.5 K to 135.9 K (-7.19 %) |
| Apr 20 2020 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Buy | M | 8.49 | 40,000 | 339,600 | 146,466 | 106.5 K to 146.5 K (+37.57 %) |
| Mar 30 2020 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Option Exercise | M | 5.40 | 2,291 | 12,371 | 103,122 | |
| Mar 30 2020 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Buy | M | 5.40 | 2,291 | 12,371 | 106,466 | 104.2 K to 106.5 K (+2.20 %) |
| Mar 02 2020 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Option Exercise | M | 5.40 | 2,291 | 12,371 | 105,413 | |
| Mar 02 2020 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Buy | M | 5.40 | 2,291 | 12,371 | 104,175 | 101.9 K to 104.2 K (+2.25 %) |
| Feb 06 2020 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Option Exercise | M | 24.99 | 2,396 | 59,876 | 111,652 | |
| Feb 06 2020 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Option Exercise | M | 5.40 | 2,291 | 12,371 | 107,704 | |
| Feb 06 2020 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Buy | M | 24.99 | 2,396 | 59,876 | 101,884 | 99.5 K to 101.9 K (+2.41 %) |
| Feb 06 2020 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Buy | M | 5.40 | 2,291 | 12,371 | 99,488 | 97.2 K to 99.5 K (+2.36 %) |
| Jan 07 2020 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Option Exercise | A | 113.20 | 80,000 | 9,056,000 | 80,000 | |
| Jan 07 2020 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Grant | A | 0.00 | 40,000 | 0 | 97,197 | 57.2 K to 97.2 K (+69.93 %) |
| Jan 07 2020 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Option Exercise | A | 113.20 | 80,000 | 9,056,000 | 80,000 | |
| Jan 07 2020 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Grant | A | 0.00 | 40,000 | 0 | 97,197 | 57.2 K to 97.2 K (+69.93 %) |
| Dec 26 2019 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Option Exercise | M | 24.99 | 317 | 7,922 | 114,048 | |
| Dec 26 2019 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Option Exercise | M | 5.40 | 1 | 5 | 109,995 | |
| Dec 26 2019 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Buy | M | 24.99 | 317 | 7,922 | 56,917 | 56.6 K to 56.9 K (+0.56 %) |
| Dec 26 2019 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Buy | M | 5.40 | 1 | 5 | 56,600 | 56.6 K to 56.6 K (0.00 %) |
| Dec 20 2019 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Gift | G | 0.00 | 10,000 | 0 | 56,599 | 66.6 K to 56.6 K (-15.02 %) |
| Aug 23 2019 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Option Exercise | M | 24.99 | 556 | 13,894 | 114,365 | |
| Aug 23 2019 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Option Exercise | M | 5.40 | 2 | 11 | 109,996 | |
| Aug 23 2019 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Option Exercise | M | 8.50 | 51,810 | 440,385 | 0 | |
| Aug 23 2019 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Buy | M | 24.99 | 556 | 13,894 | 66,599 | 66 K to 66.6 K (+0.84 %) |
| Aug 23 2019 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Buy | M | 5.40 | 2 | 11 | 66,043 | 66 K to 66 K (0.00 %) |
| Aug 23 2019 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 91.12 | 1,736 | 158,177 | 66,041 | 67.8 K to 66 K (-2.56 %) |
| Aug 23 2019 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 89.24 | 1,622 | 144,753 | 67,777 | 69.4 K to 67.8 K (-2.34 %) |
| Aug 23 2019 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 88.24 | 4,544 | 400,967 | 69,399 | 73.9 K to 69.4 K (-6.15 %) |
| Aug 23 2019 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 86.58 | 3,619 | 313,326 | 73,943 | 77.6 K to 73.9 K (-4.67 %) |
| Aug 23 2019 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 85.89 | 28,446 | 2,443,093 | 77,562 | 106 K to 77.6 K (-26.83 %) |
| Aug 23 2019 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 85.03 | 11,843 | 1,006,996 | 106,008 | 117.9 K to 106 K (-10.05 %) |
| Aug 23 2019 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Buy | M | 8.50 | 51,810 | 440,385 | 117,851 | 66 K to 117.9 K (+78.45 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | BAUM CHARLES M | Director | Option Exercise | D | 14.55 | 25,000 | 363,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | BAUM CHARLES M | Director | Option Exercise | D | 10.47 | 25,000 | 261,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | BAUM CHARLES M | Director | Sell | D | 0.00 | 5,000 | 0 | 0 | 5 K to 0 (-100.00 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | BAUM CHARLES M | Director | Sell | U | 48.00 | 15,000 | 720,000 | 5,000 | 20 K to 5 K (-75.00 %) |
| Jun 11 2019 | IMMU | IMMUNOMEDICS INC | BAUM CHARLES M | Director | Option Exercise | A | 12.93 | 17,077 | 220,806 | 17,077 | |
| Jun 11 2019 | IMMU | IMMUNOMEDICS INC | BAUM CHARLES M | Director | Grant | A | 0.00 | 9,667 | 0 | 9,667 | 0 to 9.7 K |
| Feb 27 2019 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Option Exercise | M | 8.50 | 51,810 | 440,385 | 51,810 | |
| Feb 27 2019 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 79.09 | 100 | 7,909 | 66,041 | 66.1 K to 66 K (-0.15 %) |
| Feb 27 2019 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 77.96 | 2,066 | 161,064 | 66,141 | 68.2 K to 66.1 K (-3.03 %) |
| Feb 27 2019 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 76.75 | 5,687 | 436,503 | 68,207 | 73.9 K to 68.2 K (-7.70 %) |
| Feb 27 2019 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 75.77 | 18,235 | 1,381,642 | 73,894 | 92.1 K to 73.9 K (-19.79 %) |
| Feb 27 2019 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 75.17 | 25,722 | 1,933,554 | 92,129 | 117.9 K to 92.1 K (-21.83 %) |
| Feb 27 2019 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Buy | M | 8.50 | 51,810 | 440,385 | 117,851 | 66 K to 117.9 K (+78.45 %) |
| Feb 26 2019 | IMMU | IMMUNOMEDICS INC | BAUM CHARLES M | Director | Option Exercise | A | 14.89 | 22,500 | 335,025 | 22,500 | |
| Feb 25 2019 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Option Exercise | M | 21.51 | 3,542 | 76,188 | 81,458 | |
| Feb 25 2019 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Option Exercise | M | 5.40 | 2 | 11 | 109,998 | |
| Feb 25 2019 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Option Exercise | M | 24.99 | 79 | 1,974 | 114,921 | |
| Feb 25 2019 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Buy | M | 21.51 | 3,542 | 76,188 | 66,041 | 62.5 K to 66 K (+5.67 %) |
| Feb 25 2019 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Buy | M | 5.40 | 2 | 11 | 62,499 | 62.5 K to 62.5 K (0.00 %) |
| Feb 25 2019 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Buy | M | 24.99 | 79 | 1,974 | 62,497 | 62.4 K to 62.5 K (+0.13 %) |
| Jan 22 2019 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Option Exercise | A | 64.14 | 170,000 | 10,903,800 | 170,000 | |
| Oct 29 2018 | ARRY | ARRAY BIOPHARMA IN ... | BAUM CHARLES M | Option Exercise | M | 0.00 | 5,000 | 0 | 0 | ||
| Oct 29 2018 | ARRY | ARRAY BIOPHARMA IN ... | BAUM CHARLES M | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | ||
| Oct 29 2018 | ARRY | ARRAY BIOPHARMA IN ... | BAUM CHARLES M | Option Exercise | A | 14.55 | 25,000 | 363,750 | 25,000 | ||
| Oct 29 2018 | ARRY | ARRAY BIOPHARMA IN ... | BAUM CHARLES M | Buy | M | 0.00 | 5,000 | 0 | 15,000 | 10 K to 15 K (+50.00 %) | |
| Aug 24 2018 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Option Exercise | M | 17.41 | 11,486 | 199,971 | 138,514 | |
| Aug 24 2018 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Option Exercise | M | 8.50 | 51,810 | 440,385 | 103,620 | |
| Aug 24 2018 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Buy | M | 17.41 | 11,486 | 199,971 | 62,418 | 50.9 K to 62.4 K (+22.55 %) |
| Aug 24 2018 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 58.40 | 1,862 | 108,734 | 50,932 | 52.8 K to 50.9 K (-3.53 %) |
| Aug 24 2018 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 57.86 | 32,514 | 1,881,325 | 52,794 | 85.3 K to 52.8 K (-38.11 %) |
| Aug 24 2018 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 56.88 | 17,434 | 991,730 | 85,308 | 102.7 K to 85.3 K (-16.97 %) |
| Aug 24 2018 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Buy | M | 8.50 | 51,810 | 440,385 | 102,742 | 50.9 K to 102.7 K (+101.72 %) |
| Feb 12 2018 | ARRY | ARRAY BIOPHARMA IN ... | BAUM CHARLES M | Option Exercise | M | 5.13 | 25,000 | 128,250 | 0 | ||
| Feb 12 2018 | ARRY | ARRAY BIOPHARMA IN ... | BAUM CHARLES M | Option Exercise | M | 5.95 | 25,000 | 148,750 | 0 | ||
| Feb 12 2018 | ARRY | ARRAY BIOPHARMA IN ... | BAUM CHARLES M | Sell | S | 16.90 | 50,000 | 845,000 | 10,000 | 60 K to 10 K (-83.33 %) | |
| Feb 12 2018 | ARRY | ARRAY BIOPHARMA IN ... | BAUM CHARLES M | Buy | M | 5.13 | 25,000 | 128,250 | 60,000 | 35 K to 60 K (+71.43 %) | |
| Feb 12 2018 | ARRY | ARRAY BIOPHARMA IN ... | BAUM CHARLES M | Buy | M | 5.95 | 25,000 | 148,750 | 35,000 | 10 K to 35 K (+250.00 %) | |
| Jan 22 2018 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Option Exercise | A | 27.00 | 185,000 | 4,995,000 | 185,000 | |
| Oct 27 2017 | ARRY | ARRAY BIOPHARMA IN ... | BAUM CHARLES M | Option Exercise | M | 0.00 | 5,000 | 0 | 0 | ||
| Oct 27 2017 | ARRY | ARRAY BIOPHARMA IN ... | BAUM CHARLES M | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | ||
| Oct 27 2017 | ARRY | ARRAY BIOPHARMA IN ... | BAUM CHARLES M | Option Exercise | A | 10.47 | 25,000 | 261,750 | 25,000 | ||
| Oct 27 2017 | ARRY | ARRAY BIOPHARMA IN ... | BAUM CHARLES M | Buy | M | 10.47 | 5,000 | 52,350 | 10,000 | 5 K to 10 K (+100.00 %) | |
| May 11 2017 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Option Exercise | A | 8.49 | 167,204 | 1,419,562 | 167,204 | |
| May 11 2017 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Option Exercise | D | 8.49 | 167,204 | 1,419,562 | 0 | |
| Mar 30 2017 | ARRY | ARRAY BIOPHARMA IN ... | BAUM CHARLES M | Option Exercise | M | 3.87 | 25,000 | 96,750 | 0 | ||
| Mar 30 2017 | ARRY | ARRAY BIOPHARMA IN ... | BAUM CHARLES M | Sell | S | 9.27 | 25,000 | 231,750 | 5,000 | 30 K to 5 K (-83.33 %) | |
| Mar 30 2017 | ARRY | ARRAY BIOPHARMA IN ... | BAUM CHARLES M | Buy | M | 3.87 | 25,000 | 96,750 | 30,000 | 5 K to 30 K (+500.00 %) | |
| Jan 30 2017 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Option Exercise | A | 5.40 | 110,000 | 594,000 | 110,000 | |
| Oct 31 2016 | ARRY | ARRAY BIOPHARMA IN ... | BAUM CHARLES M | Option Exercise | M | 0.00 | 5,000 | 0 | 0 | ||
| Oct 31 2016 | ARRY | ARRAY BIOPHARMA IN ... | BAUM CHARLES M | Option Exercise | A | 5.95 | 25,000 | 148,750 | 25,000 | ||
| Oct 31 2016 | ARRY | ARRAY BIOPHARMA IN ... | BAUM CHARLES M | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | ||
| Oct 31 2016 | ARRY | ARRAY BIOPHARMA IN ... | BAUM CHARLES M | Buy | M | 5.83 | 5,000 | 29,150 | 5,000 | 0 to 5 K | |
| Jun 14 2016 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | PRESIDENT & CEO | Buy | P | 7.05 | 20,000 | 141,070 | 48,556 | 28.6 K to 48.6 K (+70.04 %) |
| Jan 26 2016 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Option Exercise | A | 24.99 | 115,000 | 2,873,850 | 115,000 | |
| Nov 02 2015 | ARRY | ARRAY BIOPHARMA IN ... | BAUM CHARLES M | Option Exercise | A | 5.13 | 25,000 | 128,250 | 25,000 | ||
| Nov 02 2015 | ARRY | ARRAY BIOPHARMA IN ... | BAUM CHARLES M | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | ||
| May 12 2015 | ARRY | ARRAY BIOPHARMA IN ... | BAUM CHARLES M | Director | Option Exercise | M | 3.86 | 25,000 | 96,500 | 0 | |
| May 12 2015 | ARRY | ARRAY BIOPHARMA IN ... | BAUM CHARLES M | Director | Sell | S | 7.38 | 25,000 | 184,483 | 0 | 25 K to 0 (-100.00 %) |
| May 12 2015 | ARRY | ARRAY BIOPHARMA IN ... | BAUM CHARLES M | Director | Buy | M | 3.86 | 25,000 | 96,500 | 25,000 | 0 to 25 K |
| Feb 05 2015 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President and CEO | Option Exercise | A | 21.51 | 85,000 | 1,828,350 | 85,000 | |
| Jul 25 2014 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President and CEO | Option Exercise | M | 8.49 | 11,778 | 99,995 | 167,204 | |
| Jul 25 2014 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President and CEO | Buy | M | 8.49 | 11,778 | 99,995 | 28,556 | 16.8 K to 28.6 K (+70.20 %) |
| May 23 2014 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President and CEO | Option Exercise | A | 17.41 | 150,000 | 2,611,500 | 150,000 | |
| Feb 19 2014 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President and CEO | Option Exercise | M | 8.49 | 11,778 | 99,995 | 178,982 | |
| Feb 19 2014 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President and CEO | Buy | M | 8.49 | 11,778 | 99,995 | 16,778 | 5 K to 16.8 K (+235.56 %) |
| Nov 26 2013 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President and CEO | Buy | P | 16.96 | 5,000 | 84,819 | 5,000 | 0 to 5 K |
| Jul 18 2013 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President and CEO | Option Exercise | A | 8.50 | 207,240 | 1,761,540 | 207,240 |
Page: 1